Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

Clicks: 219
ID: 82005
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
boffito2020perspectivesaids Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Boffito, M.
Journal aids research and human retroviruses
Year 2020
DOI
10.1089/aid.2019.0171
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.